Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$103.20
-0.6%
$109.51
$77.56
$116.04
$25.10B0.682.26 million shs1.40 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$146.13
-0.5%
$155.26
$143.13
$175.97
$352.14B0.537.38 million shs6.18 million shs
McKesson Co. stock logo
MCK
McKesson
$543.37
+0.6%
$528.15
$352.34
$544.81
$71.40B0.45686,507 shs654,667 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
-0.59%-4.61%-8.33%-2.37%+28.37%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.47%-1.22%-7.49%-8.38%-10.14%
McKesson Co. stock logo
MCK
McKesson
+0.64%+3.53%+0.72%+11.97%+51.26%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.3471 of 5 stars
1.34.03.33.61.71.73.1
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9276 of 5 stars
3.23.04.23.93.62.51.9
McKesson Co. stock logo
MCK
McKesson
4.8151 of 5 stars
2.45.03.33.02.62.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.55
Moderate Buy$103.07-0.12% Downside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8620.34% Upside
McKesson Co. stock logo
MCK
McKesson
2.83
Moderate Buy$533.50-1.82% Downside

Current Analyst Ratings

Latest JNJ, CAH, and MCK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/15/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
4/15/2024
McKesson Co. stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$522.00 ➝ $548.00
4/10/2024
McKesson Co. stock logo
MCK
McKesson
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$510.00 ➝ $570.00
3/13/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
3/6/2024
McKesson Co. stock logo
MCK
McKesson
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$575.00 ➝ $620.00
2/28/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
(Data available from 4/27/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$205.01B0.12$8.66 per share11.92($11.20) per share-9.21
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.14$13.44 per share10.87$28.57 per share5.11
McKesson Co. stock logo
MCK
McKesson
$276.71B0.26$32.69 per share16.62($10.99) per share-49.44

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$261M$2.5440.6312.961.000.30%-57.44%3.89%5/2/2024 (Confirmed)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.1113.372.4545.26%36.43%15.01%7/18/2024 (Estimated)
McKesson Co. stock logo
MCK
McKesson
$3.56B$22.0724.6217.491.420.99%-262.63%5.96%5/7/2024 (Confirmed)

Latest JNJ, CAH, and MCK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
McKesson Co. stock logo
MCK
McKesson
$6.39N/A-$6.39N/AN/AN/A  
5/2/2024N/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.96N/A-$1.96N/AN/AN/A  
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
2/7/2024Q3 2024
McKesson Co. stock logo
MCK
McKesson
$7.05$7.74+$0.69$11.06$77.93 billion$80.90 billion    
2/1/2024Q2 2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.56$1.82+$0.26$2.21$57.02 billion$57.45 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.001.94%+1.00%78.74%27 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.26%+5.70%29.68%63 Years
McKesson Co. stock logo
MCK
McKesson
$2.480.46%+11.80%11.24%16 Years

Latest JNJ, CAH, and MCK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.47%5/31/20246/3/20247/1/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
2/6/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50061.92%3/28/20244/1/20244/15/2024
2/1/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.5%2/29/20243/1/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.98
0.50
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.38
1.16
0.91
McKesson Co. stock logo
MCK
McKesson
N/A
0.92
0.50

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
McKesson Co. stock logo
MCK
McKesson
85.07%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.15%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
McKesson Co. stock logo
MCK
McKesson
0.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,000243.23 million242.87 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.41 billionOptionable
McKesson Co. stock logo
MCK
McKesson
51,000131.41 million131.13 millionOptionable

JNJ, CAH, and MCK Headlines

SourceHeadline
Baltimore principal’s racist rant was an AI fake. His colleague was arrested.Baltimore principal’s racist rant was an AI fake. His colleague was arrested.
msn.com - April 26 at 11:52 PM
McKesson (NYSE:MCK) Reaches New 12-Month High at $544.36McKesson (NYSE:MCK) Reaches New 12-Month High at $544.36
marketbeat.com - April 26 at 8:11 PM
McKesson (MCK) Rises But Trails Market: What Investors Should KnowMcKesson (MCK) Rises But Trails Market: What Investors Should Know
zacks.com - April 26 at 7:16 PM
Stevens Capital Management LP Has $1.26 Million Stake in McKesson Co. (NYSE:MCK)Stevens Capital Management LP Has $1.26 Million Stake in McKesson Co. (NYSE:MCK)
marketbeat.com - April 26 at 5:58 PM
Why McKesson (MCK) is a Top Momentum Stock for the Long-TermWhy McKesson (MCK) is a Top Momentum Stock for the Long-Term
zacks.com - April 26 at 10:55 AM
McKesson (NYSE:MCK) Upgraded by StockNews.com to Strong-BuyMcKesson (NYSE:MCK) Upgraded by StockNews.com to Strong-Buy
marketbeat.com - April 25 at 11:14 PM
McKesson Co. (NYSE:MCK) Shares Purchased by Alaska Permanent Fund CorpMcKesson Co. (NYSE:MCK) Shares Purchased by Alaska Permanent Fund Corp
marketbeat.com - April 25 at 10:31 AM
Buy Rating Reaffirmed for McKesson Amid Strong Growth Prospects and OptumRx Contract WinBuy Rating Reaffirmed for McKesson Amid Strong Growth Prospects and OptumRx Contract Win
markets.businessinsider.com - April 25 at 9:50 AM
Ontada Names Jade Cusick Chief Commercial OfficerOntada Names Jade Cusick Chief Commercial Officer
finance.yahoo.com - April 25 at 9:50 AM
The Supreme Court Eliminates the Right to Mass Protest in Three U.S. StatesThe Supreme Court Eliminates the Right to Mass Protest in Three U.S. States
msn.com - April 25 at 9:50 AM
Leerink Partnrs Weighs in on McKesson Co.s Q3 2025 Earnings (NYSE:MCK)Leerink Partnrs Weighs in on McKesson Co.'s Q3 2025 Earnings (NYSE:MCK)
americanbankingnews.com - April 25 at 2:36 AM
Wynn Capital LLC Invests $1.98 Million in McKesson Co. (NYSE:MCK)Wynn Capital LLC Invests $1.98 Million in McKesson Co. (NYSE:MCK)
marketbeat.com - April 24 at 6:36 PM
Outperforming Pharma Stock Ready To Run HigherOutperforming Pharma Stock Ready To Run Higher
forbes.com - April 24 at 1:47 PM
McKesson Co. to Issue Quarterly Dividend of $0.62 (NYSE:MCK)McKesson Co. to Issue Quarterly Dividend of $0.62 (NYSE:MCK)
marketbeat.com - April 24 at 10:36 AM
Barclays Reaffirms Their Buy Rating on McKesson (MCK)Barclays Reaffirms Their Buy Rating on McKesson (MCK)
markets.businessinsider.com - April 24 at 8:46 AM
McKesson Corporation Declares Quarterly DividendMcKesson Corporation Declares Quarterly Dividend
businesswire.com - April 24 at 8:00 AM
Q3 2025 EPS Estimates for McKesson Co. (NYSE:MCK) Raised by AnalystQ3 2025 EPS Estimates for McKesson Co. (NYSE:MCK) Raised by Analyst
marketbeat.com - April 24 at 6:49 AM
SCOTUS should be protecting protesters’ rights | Not to Get Political ButSCOTUS should be protecting protesters’ rights | Not to Get Political But
dailyfreepress.com - April 24 at 3:46 AM
Q2 2025 EPS Estimates for McKesson Co. Raised by Leerink Partnrs (NYSE:MCK)Q2 2025 EPS Estimates for McKesson Co. Raised by Leerink Partnrs (NYSE:MCK)
americanbankingnews.com - April 24 at 2:44 AM
VIDEO: Maryland officer hits suspect 8 times in head after being spat onVIDEO: Maryland officer hits suspect 8 times in head after being spat on
wpde.com - April 23 at 10:45 PM
BLM activist DeRay McKesson still hounded by wild lawsuitBLM activist DeRay McKesson still hounded by 'wild' lawsuit
baltimoresun.com - April 23 at 5:45 PM
McKesson Co. (NYSE:MCK) Shares Sold by New York State Common Retirement FundMcKesson Co. (NYSE:MCK) Shares Sold by New York State Common Retirement Fund
marketbeat.com - April 23 at 12:28 PM
Q2 2025 Earnings Estimate for McKesson Co. Issued By Leerink Partnrs (NYSE:MCK)Q2 2025 Earnings Estimate for McKesson Co. Issued By Leerink Partnrs (NYSE:MCK)
marketbeat.com - April 23 at 6:31 AM
Buy Rating Affirmed: McKesson’s Strategic Growth Bolstered by OptumRx Contract WinBuy Rating Affirmed: McKesson’s Strategic Growth Bolstered by OptumRx Contract Win
markets.businessinsider.com - April 23 at 3:10 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cardinal Health logo

Cardinal Health

NYSE:CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
McKesson logo

McKesson

NYSE:MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.